We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$330M
AUM Growth
+$19M
Cap. Flow
+$2.32M
Cap. Flow %
0.7%
Top 10 Hldgs %
27.55%
Holding
108
New
3
Increased
30
Reduced
33
Closed

Top Buys

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$3.44M
2
TMO icon
Thermo Fisher Scientific
TMO
+$770K
3
NEE icon
NextEra Energy
NEE
+$526K
4
AMZN icon
Amazon
AMZN
+$352K
5
DIS icon
Walt Disney
DIS
+$272K

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Healthcare 13.66%
3 Industrials 12.3%
4 Consumer Staples 10.62%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFC icon
101
VF Corp
VFC
$5.63B
$255K 0.08%
3,120
CLX icon
102
Clorox
CLX
$11.6B
$247K 0.07%
1,375
MAS icon
103
Masco
MAS
$14.1B
$235K 0.07%
4,000
UNP icon
104
Union Pacific
UNP
$174B
$224K 0.07%
1,020
WOR icon
105
Worthington Enterprises
WOR
$2.75B
$214K 0.06%
5,677
IWF icon
106
iShares Russell 1000 Growth ETF
IWF
$121B
$206K 0.06%
+3,040
New +$196K
TXN icon
107
Texas Instruments
TXN
$252B
$203K 0.06%
1,060
IXN icon
108
iShares Global Tech ETF
IXN
$8.32B
$202K 0.06%
+3,600
New +$194K

Similar funds

Boston Research & Management's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Research & Management held 108 positions worth $330M, up 6.1% from $311M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 2.8%. Boston Research & Management opened 3 new positions and made no exits, leaving the 108-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q2 2021 buy was Lockheed Martin: 8,945 shares worth $3.38M.
  • Boston Research & Management added most to Thermo Fisher Scientific in Q2 2021, an estimated $770K increase.
  • Boston Research & Management's biggest Q2 2021 reduction was 3M, cutting an estimated $2.9M.
  • Boston Research & Management's ten largest holdings make up 28% of its $330M portfolio in Q2 2021.
  • Boston Research & Management opened 3 new positions and closed 0 in Q2 2021.
  • Boston Research & Management's portfolio value rose 6.1% quarter-over-quarter to $330M.

Based on Boston Research & Management's 13F filing for Q2 2021, filed 11 Aug 2021.